Sign In
Buy SELB
$0.88
+0 (+0%)
At Close: Feb 12, 2024
Topline data from Phase 2b study of Descartes-08, the Company's potential first-in-class mRNA CAR-T cell therapy in myasthenia gravis (MG) remains on track for mid-2024
Durable depletion of autoantibodies and clinically meaningful improvements in myasthenia gravis (MG) severity scores observed after one-year follow-up period without need for lymphodepleting chemother
Selecta Biosciences Announces Merger with Cartesian Therapeutics
08:05am, Monday, 13'th Nov 2023
– Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease –
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
04:03pm, Tuesday, 31'st Oct 2023
WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic the
Selecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue Estimates
09:31am, Thursday, 17'th Aug 2023
Selecta Biosciences, Inc. (SELB) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.06 per share a year ago.
– Company to continue focusing on advancement of SEL-212, a potential treatment for chronic refractory gout; Biologics License Application (BLA) filing on track for 1H 2024 –
Selecta Biosciences, Inc. (SELB) Q1 2023 Earnings Call Transcript
07:06pm, Thursday, 04'th May 2023
Selecta Biosciences, Inc. (NASDAQ:SELB ) Q1 2023 Earnings Conference Call May 4, 2023 8:30 AM ET Company Participants Blaine Davis - CFO Carsten Brunn - CEO, President & Director Peter Traber - Chief
WATERTOWN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic th
4 Hot Penny Stocks To Watch With News This Week
09:01am, Tuesday, 21'st Mar 2023
Penny stocks to watch this week. The post 4 Hot Penny Stocks To Watch With News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Selecta Biosciences, Inc. (SELB) Q4 2022 Earnings Call Transcript
03:16pm, Thursday, 02'nd Mar 2023
Selecta Biosciences, Inc. (NASDAQ:SELB ) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Blaine Davis - Chief Financial Officer Carsten Brunn - President, Chief Executiv
Best Penny Stocks To Buy? 4 Stocks Under $3 To Watch This Week
02:47pm, Monday, 13'th Feb 2023
Penny stocks under $3 to watch this week. The post Best Penny Stocks To Buy?
The 7 Best Biotech Stocks to Buy for February 2023
01:51pm, Tuesday, 07'th Feb 2023
While unpredictable compared to other sectors due to the ebb and flow of clinical trials, the best biotech stocks to buy offer investors incredible upside opportunities. Better yet, the volatility lar
Selecta: Despite Challenges, Dissolve Topline Data Could Move The Stock
02:43am, Tuesday, 06'th Dec 2022
I covered SELB twice. The gout phase 3 trial has certain challenges.
Selecta Biosciences, Inc. (SELB) Q3 2022 Earnings Call Transcript
02:18am, Saturday, 05'th Nov 2022
Selecta Biosciences, Inc. (NASDAQ:SELB ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Carsten Brunn - President and Chief Executive Officer Kevin Tan - Chief Finan
What The Stock Market Did Today & Top Penny Stocks To Watch Now
09:50pm, Wednesday, 28'th Sep 2022
Hot penny stocks to watch & what happened in the stock market today. The post What The Stock Market Did Today & Top Penny Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Inf
